Auna S.A. (NYSE:AUNA – Get Free Report) President Leon Jesus Zamora acquired 5,814 shares of the business’s stock in a transaction that occurred on Wednesday, May 20th. The stock was purchased at an average price of $4.39 per share, for a total transaction of $25,523.46. Following the acquisition, the president directly owned 15,914 shares in the company, valued at approximately $69,862.46. This trade represents a 57.56% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Leon Jesus Zamora also recently made the following trade(s):
- On Friday, May 29th, Leon Jesus Zamora purchased 6,420 shares of Auna stock. The shares were bought at an average price of $4.15 per share, for a total transaction of $26,643.00.
- On Thursday, May 28th, Leon Jesus Zamora purchased 9,220 shares of Auna stock. The shares were bought at an average price of $4.17 per share, for a total transaction of $38,447.40.
- On Tuesday, May 26th, Leon Jesus Zamora purchased 30,000 shares of Auna stock. The shares were bought at an average price of $4.39 per share, for a total transaction of $131,700.00.
- On Wednesday, May 27th, Leon Jesus Zamora purchased 23,273 shares of Auna stock. The shares were bought at an average price of $4.20 per share, for a total transaction of $97,746.60.
- On Tuesday, May 26th, Leon Jesus Zamora purchased 8,727 shares of Auna stock. The shares were bought at an average price of $4.24 per share, for a total transaction of $37,002.48.
Auna Stock Up 9.4%
NYSE AUNA traded up $0.39 during trading hours on Monday, hitting $4.54. 482,885 shares of the company were exchanged, compared to its average volume of 388,856. The company has a 50 day moving average of $5.20 and a two-hundred day moving average of $5.01. The company has a quick ratio of 1.00, a current ratio of 1.09 and a debt-to-equity ratio of 1.76. Auna S.A. has a 52-week low of $4.09 and a 52-week high of $6.85. The firm has a market cap of $336.01 million, a price-to-earnings ratio of 17.46 and a beta of 0.82.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the company. JPMorgan Chase & Co. lowered their price objective on Auna from $6.00 to $5.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. Wall Street Zen cut Auna from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 16th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research report on Friday, March 27th. Finally, Zacks Research cut Auna from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Auna has an average rating of “Hold” and an average target price of $6.97.
Read Our Latest Analysis on AUNA
Institutional Trading of Auna
Large investors have recently made changes to their positions in the company. World Investment Advisors acquired a new stake in shares of Auna in the 4th quarter valued at about $52,000. Virtu Financial LLC acquired a new stake in shares of Auna in the 3rd quarter valued at about $75,000. Millennium Management LLC acquired a new stake in shares of Auna in the 3rd quarter valued at about $83,000. Clear Harbor Asset Management LLC acquired a new stake in shares of Auna in the 4th quarter valued at about $63,000. Finally, Sanctuary Advisors LLC acquired a new stake in shares of Auna in the 1st quarter valued at about $71,000.
About Auna
Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.
The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.
Read More
- Five stocks we like better than Auna
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.
